| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Yuditiya Purwosunu | Q54235372 |
| Akihiko Sekizawa | Q92816405 | ||
| Antonio Farina | Q46209842 | ||
| P2093 | author name string | Takashi Okai | |
| Hiroshi Saito | |||
| Keiko Koide | |||
| Ryu Matsuoka | |||
| Shiho Okazaki | |||
| P2860 | cites work | Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood. | Q51033450 |
| Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. | Q51836356 | ||
| Expandability of haemopoietic progenitors in first trimester fetal and maternal blood: implications for non-invasive prenatal diagnosis. | Q52117344 | ||
| Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. | Q53782517 | ||
| Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. | Q54646324 | ||
| High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. | Q54648888 | ||
| Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. | Q54652148 | ||
| The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. | Q54777020 | ||
| FETAL LEUKOCYTES IN THE MATERNAL CIRCULATION AFTER DELIVERY | Q56210139 | ||
| Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study | Q56764725 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| High gradient magnetic cell separation with MACS | Q57339991 | ||
| UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation | Q57523616 | ||
| Prenatal exclusion of β thalassaemia major by examination of maternal plasma | Q58029823 | ||
| Isolation of fetal DNA from nucleated erythrocytes in maternal blood | Q24558688 | ||
| Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum | Q24567463 | ||
| Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting | Q24598225 | ||
| Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
| Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. | Q30704921 | ||
| Pathogenesis and genetics of pre-eclampsia | Q33934445 | ||
| Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis | Q34107990 | ||
| Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia | Q34322623 | ||
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
| Rapid clearance of fetal DNA from maternal plasma | Q34388637 | ||
| Microsatellite alterations in plasma DNA of small cell lung cancer patients. | Q34394739 | ||
| Microsatellite alterations in serum DNA of head and neck cancer patients | Q34394745 | ||
| mRNA of placental origin is readily detectable in maternal plasma. | Q34960254 | ||
| Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time | Q36274725 | ||
| Non-invasive antenatal RHD typing | Q36431820 | ||
| Development of non-invasive fetal DNA diagnosis from maternal blood | Q36702786 | ||
| Improved fetal nucleated erythrocyte sorting purity using intracellular antifetal hemoglobin and Hoechst 33342. | Q36827475 | ||
| Increased total cell-free DNA in the serum of pregnant women carrying a fetus affected by trisomy 21. | Q38451572 | ||
| Fetal cells in the maternal blood. Lack of response of fetal cells in maternal blood to mitogens and mixed leukocyte culture | Q39828347 | ||
| Life-span of the fetal red blood cell | Q40043189 | ||
| Risk evaluation of CVS. | Q40577967 | ||
| Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction--a pilot study | Q40588231 | ||
| Immunology of human placental implantation: clinical implications of our current understanding | Q41457939 | ||
| Mechanisms underlying immunologic states during pregnancy: possible association of the sympathetic nervous system | Q42477516 | ||
| Fetal and maternal progenitor cells in co-culture respond equally to erythropoietin | Q43825066 | ||
| New technique using galactose-specific lectin for isolation of fetal cells from maternal blood | Q43866043 | ||
| Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA. | Q44080646 | ||
| Analysis of peripheral maternal blood samples for the presence of placenta-derived cells using Y-specific probes and McAb H315. | Q44674147 | ||
| Placental histology in fetuses between 18 and 23 weeks' gestation with abnormal karyotype | Q44971902 | ||
| Non-invasive first trimester determination of fetal gender: a new approach for prenatal diagnosis of haemophilia | Q45855202 | ||
| Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination | Q45859237 | ||
| Anatomical relationship between fetus and mother | Q46121582 | ||
| Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood | Q46167117 | ||
| Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma | Q47391690 | ||
| Improved prenatal detection of a fetal point mutation for achondroplasia by the use of size-fractionated circulatory DNA in maternal plasma--case report | Q47399906 | ||
| Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood | Q47690383 | ||
| Charge flow separation: quantification of nucleated red blood cells in maternal blood during pregnancy | Q47989474 | ||
| Maternal plasma fetal DNA as a marker for preterm labour. | Q50851221 | ||
| Disturbed feto-maternal cell traffic in preeclampsia. | Q50891524 | ||
| Isolation of fetal erythroid cells from maternal blood based on expression of erythropoietin receptors. | Q50944197 | ||
| P433 | issue | 6 | |
| P921 | main subject | diagnosis | Q16644043 |
| P304 | page(s) | 747-764 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Obstetrics and Gynaecology Research | Q15767555 |
| P1476 | title | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood | |
| P478 | volume | 33 |
| Q38395133 | Cystic fibrosis: a look into the future of prenatal screening and therapy |
| Q35853485 | Efficiency of manual scanning in recovering rare cellular events identified by fluorescence in situ hybridization: simulation of the detection of fetal cells in maternal blood |
| Q35846774 | Embryonic-maternal cross-talk via exosomes: potential implications |
| Q59001540 | Fetal Nucleic Acids in Maternal Circulation: A Genetic Resource for Noninvasive Prenatal Diagnosis |
| Q38868916 | Fetal-specific hypermethylated RASSF1A quantification in pregnancy. |
| Q49720663 | Investigating Pregnancy Outcomes After Abnormal Cell-Free DNA Test Results |
| Q37821658 | Micronuclei and their association with sperm abnormalities, infertility, pregnancy loss, pre-eclampsia and intra-uterine growth restriction in humans |
| Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
| Q35024221 | Tay-Sachs disease: current perspectives from Australia |
| Q35104321 | Validation of automatic scanning of microscope slides in recovering rare cellular events: application for detection of fetal cells in maternal blood |
Search more.